Recently, Chitianhua announced a profit warning, forecasting a net loss for the fiscal year 2025. As a diversified enterprise primarily engaged in fertilizers, chemical products, and pharmaceutical intermediates, Chitianhua has faced mounting pressure on profitability in recent years due to cyclical industry fluctuations, elevated raw material costs, and weak market demand. The company attributes its projected 2025 loss mainly to declining gross margins in its fertilizer segment, insufficient cost absorption from fixed expenses during production line shutdowns for maintenance, and new projects that have yet to generate meaningful returns in their initial phase. Additionally, stricter environmental regulations and rising energy costs have further squeezed profit margins. Despite these short-term challenges, Chitianhua emphasized its ongoing efforts to optimize its industrial structure, accelerate transformation toward high-value fine chemicals and pharmaceutical intermediates, and enhance cost control and operational efficiency. Investors should closely monitor the company’s subsequent operational improvement measures and the pace of industry recovery to assess whether its long-term investment value holds potential for recovery.
近日，赤天化（Chitianhua）发布业绩预告，预计2025年度将出现亏损。作为一家主营化肥、化工产品及医药中间体的综合性企业，赤天化近年来受行业周期性波动、原材料价格高企以及市场需求疲软等多重因素影响，盈利能力持续承压。公司表示，2025年亏损主要源于化肥板块毛利率下滑、部分生产线停产检修带来的固定成本摊薄不足，以及新项目投产初期尚未形成有效收益。此外，环保政策趋严和能源成本上升也进一步压缩了利润空间。尽管面临短期挑战，赤天化强调将继续推进产业结构优化，加快向高附加值精细化工和医药中间体领域转型，并加强成本控制与内部管理效率。投资者需关注公司后续经营改善措施及行业复苏节奏，以判断其长期投资价值是否具备修复潜力。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/13000.html